| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |